BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
243 hedge funds and large institutions have $6.9B invested in bluebird bio in 2017 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 105 increasing their positions, 61 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
243
Holders Change
+2
Holders Change %
+0.83%
% of All Funds
6.07%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
45
Increased
105
Reduced
61
Closed
39
Calls
$163M
Puts
$110M
Net Calls
+$52.9M
Net Calls Change
-$6.76M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$48.9M |
| 2 |
BlackRock
New York
|
+$38.4M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$34M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$31.2M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$29.5M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$30.8M |
| 2 |
Goldman Sachs
New York
|
-$28.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$21.7M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$21.1M |
